Clindamycin phosphate - Drug Shortage Information

Public shortage context is available across 14 visible exact NDC pages for this generic family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

Family summary

Current and historical shortage references are available across related Clindamycin phosphate presentations from multiple manufacturers.

  • 4 current shortage context pages.
  • 10 historical shortage context pages.
  • 3 manufacturers represented.

Related research paths

Common brands and presentations in this family

These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

Exact NDC product pages in this shortage family

Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug NameNDC 11ManufacturerShortage Context
clindamycin phosphate 300 mg / 50mL Injection 50 mL
NDC 00338-9545-24 | 24 Bag | Baxter Healthcare Company
00338-9545-24Baxter Healthcare CompanyCurrent shortage context
clindamycin phosphate 150 mg / mL Injection 60 mL (Cleocin Phosphate)
NDC 00009-0728-09 | 5 Vial, Pharmacy Bulk Package | Pharmacia & Upjohn Company LLC
00009-0728-09Pharmacia & Upjohn Company LLCCurrent shortage context
Clindamycin phosphate 900 mg / 50mL Injection 50 mL
NDC 00338-3814-24 | 24 Bag | Baxter Healthcare Company
00338-3814-24Baxter Healthcare CompanyCurrent shortage context
Clindamycin Phosphate 150 mg / mL Injection 4 mL
NDC 25021-0115-04 | 25 Vial | Sagent Pharmaceuticals
25021-0115-04Sagent PharmaceuticalsCurrent shortage context
clindamycin phosphate 600 mg / 50mL Injection 50 mL
NDC 00338-9549-24 | 24 Bag | Baxter Healthcare Company
00338-9549-24Baxter Healthcare CompanyHistorical shortage context
clindamycin phosphate 900 mg / 50mL Injection 50 mL
NDC 00338-9553-24 | 24 Bag | Baxter Healthcare Company
00338-9553-24Baxter Healthcare CompanyHistorical shortage context
clindamycin phosphate 150 mg / mL Injection 4 mL (Cleocin Phosphate)
NDC 00009-0775-26 | 25 Vial | Pharmacia & Upjohn Company LLC
00009-0775-26Pharmacia & Upjohn Company LLCHistorical shortage context
clindamycin phosphate 150 mg / mL Injection 2 mL (Cleocin Phosphate)
NDC 00009-0870-26 | 25 Vial | Pharmacia & Upjohn Company LLC
00009-0870-26Pharmacia & Upjohn Company LLCHistorical shortage context
clindamycin phosphate 150 mg / mL Injection 6 mL (Cleocin Phosphate)
NDC 00009-0902-18 | 25 Vial | Pharmacia & Upjohn Company LLC
00009-0902-18Pharmacia & Upjohn Company LLCHistorical shortage context
Clindamycin phosphate 300 mg / 50mL Injection 50 mL
NDC 00338-3410-24 | 24 Bag | Baxter Healthcare Company
00338-3410-24Baxter Healthcare CompanyHistorical shortage context
Clindamycin phosphate 600 mg / 50mL Injection 50 mL
NDC 00338-3612-24 | 24 Bag | Baxter Healthcare Company
00338-3612-24Baxter Healthcare CompanyHistorical shortage context
Clindamycin phosphate 900 mg / 50mL Injection 50 mL
NDC 43066-0995-24 | 24 Bag | Baxter Healthcare Corporation
43066-0995-24Baxter Healthcare CorporationHistorical shortage context
Clindamycin Phosphate 150 mg / mL Injection 2 mL
NDC 25021-0115-02 | 25 Vial | Sagent Pharmaceuticals
25021-0115-02Sagent PharmaceuticalsHistorical shortage context
Clindamycin Phosphate 150 mg / mL Injection 6 mL
NDC 25021-0115-06 | 25 Vial | Sagent Pharmaceuticals
25021-0115-06Sagent PharmaceuticalsHistorical shortage context

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.